ASX:CUV
ASX:CUVBiotechs

3 ASX Growth Stocks With High Insider Ownership

As the Australian market navigates a period of turbulence, with indices hitting three-week lows influenced by Wall Street's subdued performance and unexpected domestic economic data, investors are increasingly seeking stability amidst volatility. In such an environment, growth companies with high insider ownership can be appealing as they often indicate strong confidence from those closest to the business, potentially offering resilience and alignment of interests in uncertain times.
ASX:JLG
ASX:JLGConstruction

3 ASX Penny Stocks With Market Caps Larger Than A$100M

The Australian market has recently hit three-week lows, influenced by Wall Street's subdued performance and unexpected domestic economic data. Despite these challenges, investors continue to explore opportunities beyond the major indices. Penny stocks, often representing smaller or newer companies, remain a relevant area for investment as they can offer growth potential at lower price points. By focusing on those with robust financials and clear growth trajectories, investors can uncover...
ASX:TNE
ASX:TNESoftware

Will New Independent Directors With Deep Tech Experience Transform Technology One's (ASX:TNE) Board Dynamics?

Technology One Limited has appointed Debra Eckersley, formerly of PwC and Bank of Queensland, and Phil Davis, with extensive leadership experience at major global technology companies, as independent Non-Executive Directors effective 1 October 2025. Their combined backgrounds in organizational culture, risk management, and scaling cloud and AI businesses could enhance the company's board expertise in governance and technological innovation. We'll examine how the addition of board members...
ASX:PDN
ASX:PDNOil and Gas

Can Paladin Energy's (ASX:PDN) PLS Cost Update Reshape Long-Term Confidence in Project Execution?

Paladin Energy recently provided an update on its Patterson Lake South (PLS) uranium project in Canada, confirming unchanged life of mine production estimates, revised cost figures, and a targeted first uranium output in 2031 following the acquisition of Fission Uranium in December 2024. This update underscores the company's ability to maintain robust project economics and clarity on development timelines, even as capital and operating costs adjust for inflation and project advancements. To...
ASX:WES
ASX:WESMultiline Retail

How Strong Earnings and Bigger Dividends at Wesfarmers (ASX:WES) Have Changed Its Investment Story

Wesfarmers Limited reported higher full-year sales and net income, announced a fully franked dividend increase, released plans for a special dividend and capital management initiative, and revealed upcoming changes in board leadership including the future appointment of Ken MacKenzie as Chairman. The combination of robust financial results and initiatives to reward shareholders signals Wesfarmers' focus on shareholder value and operational stability during a period of leadership...
ASX:SHL
ASX:SHLHealthcare

Will Strong Earnings and Final Dividend Shift Sonic Healthcare's (ASX:SHL) Investment Story?

Sonic Healthcare recently announced its full-year results for the period ended June 30, 2025, posting revenue of A$9.65 billion and net income of A$513.6 million, accompanied by a fully franked final dividend of A$0.63 per share, payable September 18, 2025. The simultaneous release of earnings figures and a clear dividend policy provides investors with both updated financial performance data and immediate clarity on shareholder returns. We'll examine how the combination of robust revenue and...
ASX:AYA
ASX:AYAHealthcare Services

Did FDA Clearance for Real-Time Plaque Detection Just Shift Artrya's (ASX:AYA) Investment Narrative?

In August 2025, Artrya Limited announced it received 510(k) clearance from the U.S. FDA for its Salix® Coronary Plaque module, enabling real-time detection of high-risk coronary plaque and integrating with its existing Salix® Coronary Anatomy platform already used commercially in the U.S. This regulatory milestone allows Artrya to expand its U.S. commercial launch, offer per-scan assessments reimbursed at the Category 1 CPT rate of US$950, and create new revenue streams for the...
ASX:HVN
ASX:HVNMultiline Retail

Why Harvey Norman (ASX:HVN) Is Up 20.7% After Lifting Dividend and Reporting Strong Earnings Growth

Harvey Norman Holdings Limited announced a fully franked dividend of A$0.145 per share for the six months ended June 30, 2025, payable on November 3, 2025, alongside its full-year earnings for the period. The company reported a substantial increase in net income and earnings per share compared to the previous year, highlighting improved performance and stronger shareholder returns. We’ll explore how Harvey Norman’s improved profitability and higher dividend payout could influence its...
ASX:NAB
ASX:NABBanks

Will NAB's (ASX:NAB) New CFO Appointment Shape Its Financial Strategy and Competitive Edge?

National Australia Bank has announced the appointment of Inder Singh as Group Chief Financial Officer and Group Executive, Strategy, with Mr. Singh joining the company in March 2026 subject to regulatory approvals. Singh’s depth of experience across investment banking and insurance is set to influence both NAB’s financial management and its overarching corporate strategy. To assess the potential impact on NAB’s investment narrative, we’ll focus on how Singh’s dual financial and strategic...